In the CSF of people with primary progressive multiple sclerosis, OCR treatment was associated with a lower proportion of B cells (Fig. 4A and B) but a similar distribution of total and memory T cells for both the CD4+ and CD8+ population (Fig. 4C–E). This evidence concerns the gene CD8A and primary progressive multiple sclerosis.